Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 188

1.

Chronic pain as a manifestation of potassium channel-complex autoimmunity.

Klein CJ, Lennon VA, Aston PA, McKeon A, Pittock SJ.

Neurology. 2012 Sep 11;79(11):1136-44. doi: 10.1212/WNL.0b013e3182698cab. Epub 2012 Aug 15.

2.

Insights from LGI1 and CASPR2 potassium channel complex autoantibody subtyping.

Klein CJ, Lennon VA, Aston PA, McKeon A, O'Toole O, Quek A, Pittock SJ.

JAMA Neurol. 2013 Feb;70(2):229-34. doi: 10.1001/jamaneurol.2013.592.

3.

Cramp-fasciculation syndrome in patients with and without neural autoantibodies.

Liewluck T, Klein CJ, Jones LK Jr.

Muscle Nerve. 2014 Mar;49(3):351-6. doi: 10.1002/mus.23935. Epub 2013 Dec 17.

PMID:
23836298
4.

Expanded phenotypes and outcomes among 256 LGI1/CASPR2-IgG-positive patients.

Gadoth A, Pittock SJ, Dubey D, McKeon A, Britton JW, Schmeling JE, Smith A, Kotsenas AL, Watson RE, Lachance DH, Flanagan EP, Lennon VA, Klein CJ.

Ann Neurol. 2017 Jul;82(1):79-92. doi: 10.1002/ana.24979.

PMID:
28628235
5.

The relevance of VGKC positivity in the absence of LGI1 and Caspr2 antibodies.

van Sonderen A, Schreurs MW, de Bruijn MA, Boukhrissi S, Nagtzaam MM, Hulsenboom ES, Enting RH, Thijs RD, Wirtz PW, Sillevis Smitt PA, Titulaer MJ.

Neurology. 2016 May 3;86(18):1692-9. doi: 10.1212/WNL.0000000000002637. Epub 2016 Apr 1.

PMID:
27037230
6.

Psychiatric Autoimmunity: N-Methyl-D-Aspartate Receptor IgG and Beyond.

Kruse JL, Lapid MI, Lennon VA, Klein CJ, Toole OO, Pittock SJ, Strand EA, Frye MA, McKeon A.

Psychosomatics. 2015 May-Jun;56(3):227-41. doi: 10.1016/j.psym.2015.01.003. Epub 2015 Feb 4.

PMID:
25975857
7.

Intracellular and non-neuronal targets of voltage-gated potassium channel complex antibodies.

Lang B, Makuch M, Moloney T, Dettmann I, Mindorf S, Probst C, Stoecker W, Buckley C, Newton CR, Leite MI, Maddison P, Komorowski L, Adcock J, Vincent A, Waters P, Irani SR.

J Neurol Neurosurg Psychiatry. 2017 Apr;88(4):353-361. doi: 10.1136/jnnp-2016-314758. Epub 2017 Jan 23.

8.

Detection of LGI1 and CASPR2 antibodies with a commercial cell-based assay in patients with very high VGKC-complex antibody levels.

Yeo T, Chen Z, Chai JYH, Tan K.

J Neurol Sci. 2017 Jul 15;378:85-90. doi: 10.1016/j.jns.2017.04.045. Epub 2017 Apr 28.

PMID:
28566186
9.

Voltage-gated potassium channel-complex autoimmunity and associated clinical syndromes.

Irani SR, Vincent A.

Handb Clin Neurol. 2016;133:185-97. doi: 10.1016/B978-0-444-63432-0.00011-6. Review.

PMID:
27112678
10.

Clinical spectrum and diagnostic value of antibodies against the potassium channel related protein complex.

Montojo MT, Petit-Pedrol M, Graus F, Dalmau J.

Neurologia. 2015 Jun;30(5):295-301. doi: 10.1016/j.nrl.2013.12.007. Epub 2014 Jan 30. Review. English, Spanish.

11.

Clinical spectrum of voltage-gated potassium channel autoimmunity.

Tan KM, Lennon VA, Klein CJ, Boeve BF, Pittock SJ.

Neurology. 2008 May 13;70(20):1883-90. doi: 10.1212/01.wnl.0000312275.04260.a0.

PMID:
18474843
12.

Neuronal voltage-gated potassium channel complex autoimmunity in children.

Dhamija R, Renaud DL, Pittock SJ, McKeon A, Lachance DH, Nickels KC, Wirrell EC, Kuntz NL, King MD, Lennon VA.

Pediatr Neurol. 2011 Apr;44(4):275-81. doi: 10.1016/j.pediatrneurol.2010.10.015.

PMID:
21397169
13.

Clinical-pathologic correlations in voltage-gated Kv1 potassium channel complex-subtyped autoimmune painful polyneuropathy.

Lahoria R, Pittock SJ, Gadoth A, Engelstad JK, Lennon VA, Klein CJ.

Muscle Nerve. 2017 Apr;55(4):520-525. doi: 10.1002/mus.25371. Epub 2017 Feb 13.

PMID:
27511450
14.

Clinical relevance of voltage-gated potassium channel–complex antibodies in children.

Hacohen Y, Singh R, Rossi M, Lang B, Hemingway C, Lim M, Vincent A.

Neurology. 2015 Sep 15;85(11):967-75.

15.

From VGKC to LGI1 and Caspr2 encephalitis: The evolution of a disease entity over time.

van Sonderen A, Schreurs MW, Wirtz PW, Sillevis Smitt PA, Titulaer MJ.

Autoimmun Rev. 2016 Oct;15(10):970-4. doi: 10.1016/j.autrev.2016.07.018. Epub 2016 Jul 30. Review.

16.

Autoimmune encephalitis with anti-leucine-rich glioma-inactivated 1 or anti-contactin-associated protein-like 2 antibodies (formerly called voltage-gated potassium channel-complex antibodies).

Bastiaansen AEM, van Sonderen A, Titulaer MJ.

Curr Opin Neurol. 2017 Jun;30(3):302-309. doi: 10.1097/WCO.0000000000000444. Review.

PMID:
28248701
17.
18.

Morvan syndrome: clinical and serological observations in 29 cases.

Irani SR, Pettingill P, Kleopa KA, Schiza N, Waters P, Mazia C, Zuliani L, Watanabe O, Lang B, Buckley C, Vincent A.

Ann Neurol. 2012 Aug;72(2):241-55. doi: 10.1002/ana.23577. Epub 2012 Apr 4.

PMID:
22473710
19.

Sleep manifestations of voltage-gated potassium channel complex autoimmunity.

Cornelius JR, Pittock SJ, McKeon A, Lennon VA, Aston PA, Josephs KA, Tippmann-Peikert M, Silber MH.

Arch Neurol. 2011 Jun;68(6):733-8. doi: 10.1001/archneurol.2011.106.

PMID:
21670396
20.

Clinical relevance of positive voltage-gated potassium channel (VGKC)-complex antibodies: experience from a tertiary referral centre.

Paterson RW, Zandi MS, Armstrong R, Vincent A, Schott JM.

J Neurol Neurosurg Psychiatry. 2014 Jun;85(6):625-30. doi: 10.1136/jnnp-2013-305218. Epub 2013 Jun 11.

Supplemental Content

Support Center